These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 35646901)

  • 1.
    Mukherjee S; Kar A; Paul P; Dey S; Biswas A; Barik S
    Front Cell Dev Biol; 2022; 10():899752. PubMed ID: 35646901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early T precursor acute lymphoblastic leukaemia/lymphoma shows differential immunophenotypic characteristics including frequent CD33 expression and in vitro response to targeted CD33 therapy.
    Khogeer H; Rahman H; Jain N; Angelova EA; Yang H; Quesada A; Ok CY; Sui D; Wei P; Al Fattani A; Pierce S; Loghavi S; Lamb A; Hu P; Thakral B; Kanagal-Shamanna R; Jorgensen JL; Jabbour EJ; Kantarjian HM; Medeiros LJ; Khoury JD
    Br J Haematol; 2019 Aug; 186(4):538-548. PubMed ID: 31115909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of T-cell acute lymphoblastic leukemia/lymphoma: Focus on near-ETP phenotype and differential impact of nelarabine.
    Morita K; Jain N; Kantarjian H; Takahashi K; Fang H; Konopleva M; El Hussein S; Wang F; Short NJ; Maiti A; Sasaki K; Garcia-Manero G; Konoplev S; Ravandi F; Khoury JD; Jabbour E
    Am J Hematol; 2021 May; 96(5):589-598. PubMed ID: 33639000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early T-cell precursor leukemia: a subtype of high risk childhood acute lymphoblastic leukemia.
    Ma M; Wang X; Tang J; Xue H; Chen J; Pan C; Jiang H; Shen S
    Front Med; 2012 Dec; 6(4):416-20. PubMed ID: 23065427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-7 receptor mutants initiate early T cell precursor leukemia in murine thymocyte progenitors with multipotent potential.
    Treanor LM; Zhou S; Janke L; Churchman ML; Ma Z; Lu T; Chen SC; Mullighan CG; Sorrentino BP
    J Exp Med; 2014 Apr; 211(4):701-13. PubMed ID: 24687960
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Xu X; Zhai Q; Jin H; Yu Y; Han D; Zhang H; Fu K; Meng B
    Int J Gen Med; 2021; 14():659-664. PubMed ID: 33658838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computational modeling of early T-cell precursor acute lymphoblastic leukemia (ETP-ALL) to identify personalized therapy using genomics.
    Kumar A; Drusbosky LM; Meacham A; Turcotte M; Bhargav P; Vasista S; Usmani S; Pampana A; Basu K; Tyagi A; Lala D; Rajagopalan S; Birajdar SC; Alam A; Ghosh Roy K; Abbasi T; Vali S; Sengar M; Chinnaswamy G; Shah BD; Cogle CR
    Leuk Res; 2019 Mar; 78():3-11. PubMed ID: 30641417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early T-cell precursor acute lymphoblastic leukemia with
    Tran T; Krause J
    Proc (Bayl Univ Med Cent); 2018 Oct; 31(4):511-513. PubMed ID: 30948995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early T-cell precursor acute lymphoblastic leukemia and other subtypes: a retrospective case report from a single pediatric center in China.
    Liu X; Zou Y; Zhang L; Chen X; Yang W; Guo Y; Chen Y; Zhang Y; Zhu X
    J Cancer Res Clin Oncol; 2021 Sep; 147(9):2775-2788. PubMed ID: 33651142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A New Treatment Strategy for Early T-Cell Precursor Acute Lymphoblastic Leukemia: A Case Report and Literature Review.
    Mao J; Xue L; Wang H; Zhu Y; Wang J; Zhao L
    Onco Targets Ther; 2021; 14():3795-3802. PubMed ID: 34168464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early Response-Based Therapy Stratification Improves Survival in Adult Early Thymic Precursor Acute Lymphoblastic Leukemia: A Group for Research on Adult Acute Lymphoblastic Leukemia Study.
    Bond J; Graux C; Lhermitte L; Lara D; Cluzeau T; Leguay T; Cieslak A; Trinquand A; Pastoret C; Belhocine M; Spicuglia S; Lheritier V; Leprêtre S; Thomas X; Huguet F; Ifrah N; Dombret H; Macintyre E; Boissel N; Asnafi V
    J Clin Oncol; 2017 Aug; 35(23):2683-2691. PubMed ID: 28605290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological and immunophenotypic features of early T cell precursor acute lymphoblastic leukaemia: A flow cytometry score for the initial diagnosis.
    Chandra D; Singh MK; Gupta R; Rahman K; Yadav DD; Sarkar MK; Gupta A; Yadav S; Kashyap R; Nityanand S
    Int J Lab Hematol; 2021 Dec; 43(6):1417-1423. PubMed ID: 34115925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Early T-Cell Precursor and Non-ETP Subtypes Among 122 Chinese Adults With Acute Lymphoblastic Leukemia.
    Zhang Y; Qian JJ; Zhou YL; Huang X; Li JH; Li XY; Li CY; Wang HP; Lou YJ; Meng HT; Yu WJ; Tong HY; Jin J; Zhu HH
    Front Oncol; 2020; 10():1423. PubMed ID: 32974153
    [No Abstract]   [Full Text] [Related]  

  • 14. [A clinical study of allogeneic hematopoietic stem cell transplantation in 23 patients with early T-cell precursor acute lymphoblastic leukemia].
    Zhu YX; Zhu MQ; Dai HP; Liu SN; Yin J; Li Z; Cui QY; Zhu XM; Wu DP; Tang XW
    Zhonghua Xue Ye Xue Za Zhi; 2019 Dec; 40(12):1021-1025. PubMed ID: 32023734
    [No Abstract]   [Full Text] [Related]  

  • 15. [Identification of Differentially Expressed Gene Core Genes in Early T-Cell Precursor Acute Lymphoblastic Leukemia and Its Regulatory Network Analysis].
    Lun YZ; Sun J; Yu ZG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Jun; 27(3):673-684. PubMed ID: 31204916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Outcome of 126 adolescent and adult T-cell acute leukemia/lymphoma patients and the prognostic significance of early T-cell precursor leukemia subtype].
    Liao HY; Sun ZY; Wang YX; Jin YM; Zhu HL; Jiang NG
    Zhonghua Xue Ye Xue Za Zhi; 2019 Jul; 40(7):561-567. PubMed ID: 32397018
    [No Abstract]   [Full Text] [Related]  

  • 17. Optimized outcome prediction of oncogenetic mutations in non-early T-cell precursor acute lymphoblastic leukemia.
    Peng LJ; Wang SS; Guo SS; Zhang JJ; Liu YF; Rousseaux S; Khochbin S; Chen B; Wang J; Mi JQ
    Immunobiology; 2022 May; 227(3):152205. PubMed ID: 35279479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FLT3 mutations in early T-cell precursor ALL characterize a stem cell like leukemia and imply the clinical use of tyrosine kinase inhibitors.
    Neumann M; Coskun E; Fransecky L; Mochmann LH; Bartram I; Sartangi NF; Heesch S; Gökbuget N; Schwartz S; Brandts C; Schlee C; Haas R; Dührsen U; Griesshammer M; Döhner H; Ehninger G; Burmeister T; Blau O; Thiel E; Hoelzer D; Hofmann WK; Baldus CD
    PLoS One; 2013; 8(1):e53190. PubMed ID: 23359050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic and clinical characterization of early T-cell precursor lymphoblastic lymphoma.
    Xu X; Paxton CN; Hayashi RJ; Dunsmore KP; Winter SS; Hunger SP; Winick NJ; Carroll WL; Loh ML; Devidas M; Gross TG; Bollard CM; Perkins SL; Miles RR
    Blood Adv; 2021 Jul; 5(14):2890-2900. PubMed ID: 34297047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long term outcome of a patient with relapsed refractory early thymic precursor acute lymphoblastic leukemia treated with daratumumab.
    Punatar S; Gokarn A; Nayak L; Bonda A; Chichra A; Mirgh S; Bagal B; Tembhare P; Subramanian P; Khattry N
    Am J Blood Res; 2021; 11(5):528-533. PubMed ID: 34824885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.